Hyperpigmentation of the teeth and tongue may occur in skin cancer patients receiving etoposide, prednisolone, vincristine, and cyclophosphamide treatment

Authors

  • Dr. M. SREENIVASULU PRINCIPAL AND PROFESSOR, DEPT OF PHARMACEUTICAL CHEMISTRY, NARAYANA PHARMACY COLLEGE, CHINTHA REDDY PALEM, NELLORE Author
  • Dr. LALITHA CHEMBETI PROFESSOR, DEPT OF PHARMACEUTICAL CHEMISTRY, NARAYANA PHARMACY COLLEGE, CHINTHA REDDY PALEM, NELLORE Author
  • .Dr. S. Niveditha Professor & Principal, DEPT OF PHARMACOGNOSY, SWATHI COLLEGE OF PHARMACY, NELLORE Author
  • Ms.Sk.Salma Sultana Asso Professor, DEPT OF Pharmacology, NARAYANA PHARMACY COLLEGE, CHINTHA REDDY PALEM, NELLORE Author
  • A. RANI Asso. Professor, DEPT OF PHARMACEUTICS, NARAYANA PHARMACY COLLEGE, CHINTHA REDDY PALEM, NELLORE Author

Abstract

Cutaneous extranodal non-Hodgkin lymphoma is an unusual cancer that often responds to chemotherapeutic drugs including cyclophosphamide, vincristine, and etoposide. Hyperpigmentation of the nails and skin is an extremely rare side effect of these medications.  A case of hyperpigmentation that extended to the tongue and teeth is shown here, however. Teeth and the tongue started to hyper pigment soon after chemotherapy began. Within a week, the hyperpigmentation cleared up without the need for any medication, surgery, or changes to one's way of life

References

Cutaneous T-cell lymphoma is the subject of Pulitzer M. Clinical laboratory medicine 2017;37:527–46.

The 2016 update on the diagnosis, risk-stratification, and treatment of cutaneous T-cell lymphoma was published by Wilcox RA. Published in 2016 in the American Journal of Hematology, volume 91, pages 151–165.

Kotz EA, Thiers BH, Anderson D. Skin T-cell lymphoma. Johns Hopkins University Journal of Dermatology and Venereology, 2003, 17(1), 131–137.

Latkowski JA, Lo Sicco K, Weed J, and Peterson E. Skin T cell lymphoma: A previously baffling diagnosis unraveled. "Dermatol Clin" published the article in 2019 with the DOI: 37: 455–69.

Downloads

Published

2026-05-30